Market Tracker

04/16 5:05pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

4.18
Data as of Apr 16
 -0.13 / -3.02%
Today’s Change
3.70
Today|||52-Week Range
5.81
+7.46%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close4.31
Today’s open4.40
Day’s range4.12 - 4.40
Volume215,512
Average volume (3 months)219,512
Market cap$420.2M
Dividend yield--
Data as of 4:01pm ET, 04/16/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.02-0.13%
RTRXRetrophin Inc+0.70+6.03%
OSIROsiris Therapeutics ...+0.11+0.87%
CGENCompugen Ltd-0.03-0.33%
Data as of 3:59pm ET, 04/16/2014

Financials

Next reporting dateMay 28, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts